Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study-Reference-Cited by-同舟云学术

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study

Published:2023-05 Issue:5 Volume:10 Page:323-333
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Man Kenneth K C,Häge Alexander,Banaschewski Tobias,Inglis Sarah K,Buitelaar Jan,Carucci Sara,Danckaerts Marina,Dittmann Ralf W,Falissard Bruno,Garas Peter,Hollis Chris,Konrad Kerstin,Kovshoff Hanna,Liddle Elizabeth,McCarthy Suzanne,Neubert Antje,Nagy Peter,Rosenthal Eric,Sonuga-Barke Edmund J S,Zuddas Alessandro,Wong Ian C K,Coghill David,Couper Tessa,Masi Gabriele,Gagliano Antonella,Lamberti Marco,Maschietto Dino,Costantino Antonella,Morosini Paola,Fazzi Maria Elisa,Oehler Klaus-Ulrich,Pitzer Martina,Fegert Jörg,Häßler Frank,Renner Tobias,Härtling Fabian,Romanos Marcel,Alfred Adam,Roessner Veit,Wallitza Susanne,Uebel-von Sandersleben Henrik

Funder

European Commission

Seventh Framework Programme

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference42 articles.

1. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder;Faraone;Neurosci Biobehav Rev,2021

2. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys;Fayyad;Atten Defic Hyperact Disord,2017

3. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review;Willcutt;Neurotherapeutics,2012

4. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases;Raman;Lancet Psychiatry,2018

5. The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities;Faraone;Neurosci Biobehav Rev,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Incident Psychosis and Mania With Prescription Amphetamines;American Journal of Psychiatry;2024-09-12

2. Should methylphenidate be included in the WHO model lists of essential medicines?;European Child & Adolescent Psychiatry;2024-09-12

3. Risques du méthylphénidate au long cours;Annales Médico-psychologiques, revue psychiatrique;2024-09

4. Tourette syndrome research highlights from 2023;F1000Research;2024-08-09

5. AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines;Journal of the American Academy of Child & Adolescent Psychiatry;2024-07